Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials.
Munveer ThindWojciech ZarebaDan AtarHarry J G M CrijnsJun ZhuHui Nam PakJames A ReiffelUlf LudwigsMattias WielochJohn StewartPeter R KoweyPublished in: Clinical cardiology (2022)
This analysis suggests that dronedarone could be an effective therapeutic option for AF with an acceptable safety profile in patients with impaired renal function.